chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; Chills; Body aches; Fatigue; Headache; Feeling so sick; I'm feeling so bad; Feeling so sick; I'm feeling so bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: NAUSEA (non-serious), outcome "unknown", described as "Nausea"; CHILLS (non-serious), outcome "unknown", described as "Chills"; PAIN (non-serious), outcome "unknown", described as "Body aches"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; HEADACHE (non-serious), outcome "unknown", described as "Headache"; MALAISE (non-serious), FEELING ABNORMAL (non-serious), outcome "unknown" and all described as "Feeling so sick; I'm feeling so bad". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The Laboratory test SARS-CoV-2 test was reported as negative.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Second rash was itchy; Second rash was on her shoulder across her breast and on her stomach area as well as on her left forearm; First rash on her arm and all over her front torso; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Second rash was itchy), RASH (Second rash was on her shoulder across her breast and on her stomach area as well as on her left forearm) and RASH (First rash on her arm and all over her front torso) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (First rash on her arm and all over her front torso). On 07-Apr-2021, the patient experienced RASH PRURITIC (Second rash was itchy) and RASH (Second rash was on her shoulder across her breast and on her stomach area as well as on her left forearm). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (Second rash was itchy), RASH (Second rash was on her shoulder across her breast and on her stomach area as well as on her left forearm) and RASH (First rash on her arm and all over her front torso) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported.  It was reported that patient took Claritin for both her rashes as treatment but it helped for the first rash but not for the second rash.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received from a registered nurse concerning a couple of females with unspecified pertinent medical history and unspecified drug reactions/allergies who on an unspecified date were vaccinated with first dose of Gardasil (yeast) (lot # not reported), 0.5 ml, IM. Concomitant therapy was not specified. On an unspecified date, the patients experienced tingling in their fingers of the arm being injected while getting the injection. The tingling resolved within a couple of minutes of receiving the shot. Medical attention was sought. At the time of reporting, the patients had recovered. The patients plan on getting was sought. At the time of reporting, the patients had recovered. The patients plan on getting their second and third doses of Gardasil (yeast). Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/14/2007.  Information has been received from a registered nurse concerning a couple of females with unspecified pertinent medical history and unspecified drug reactions/allergies who on an unspecified date were vaccinated with first dose of GARDASIL (lot # not reported), 0.5 ml, IM.  Concomitant therapy was not specified.  On an unspecified date, the patients experienced tingling in their fingers of the arm being injected while getting the injection.  The tingling resolved within a couple of minutes of receiving the shot.  Medical attention was sought.  At the time of reporting, the patients had recovered.  The patients plan on getting their second and third doses of GARDASIL.  Additional information was received from the registered nurse via telephone who reported that there might be 4 patients but was not sure.  Additional information was received from the registered nurse who reported that the event involved a few girls, number unknown.  The patients complained of hand numbness right after the injection.  No specific patient identifiers were known.  The outcome of the hand numbness was not reported.  No additional information is expected.
Severe muscle/joint aches beginning day of vaccine until three days later.  102 fever and severe chills for 36 hours beginning night of injection.  Severely swollen lymph nodes under injection arm for four days. Splotchy, hot red spots under injection site three days after injection. Swollen, extremely sore area around injection site for four days.
sore arm; This is a spontaneous report from a contactable consumer (patient's mother). This is 2nd of 2 reports.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced sore arm. The patient recovered from the event on an unspecified date.  Information on the lot/batch number has been requested.  Follow-up (14MAY2021): Follow-up attempts completed. No further information expected.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 27-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]).   On 27-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 21-Aug-2020 and the estimated date of delivery was 28-May-2021. On 27-Jan-2021 at 11:00 AM, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-second week of the pregnancy.  On 27-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Nov-2020, Ultrasound scan: confirm heart beat. On 05-Jan-2021, Ultrasound scan: (normal) anatomy scan.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   18-SEP-2020 was reported as Date of positive pregnancy test. 04-SEP-2021 was reported as Estimated date of conception. There was no maternal history of subfertility There was no complications or acute illnesses during this pregnancy to date. No family history of congenital anomalies/genetic disease. No patient's chronic or long-standing health conditions No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jan-2021: Upon internal review on 20-Jul-2021, patient, products, events, analysis and regulatory reports tabs were updated.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
COVID Bivalent Booster was administered as first vaccination in COVID-19 vaccination series.
pt recvd vax;w/in 12-24 hrs later, pt devel inflam at inject site & a knot below inject site;
Sore arm at injection site, body/joint aches, extreme headache, fever, chills, nausea
Felt foggy laying on the couch, then my arm hurt at the injection spot, then I stood up and fainted, then vomited for about 2 hours.
4-6-2006 THE MORNING AFTER THE TD SHOT IN HIS LEFT ARM, MY HUSBAND HAD INCREASING FEVER TO 101F, LEFT FACIAL SWELLING, LEFT THROAT PAIN AND SWELLING AND GRADUAL LOSS OF VOICE.  THIS CONTINUED AND HE WENT BACK TO THE EMERGENCY ROOM ON 4-10-06. HIS SYMPTOMS DID NOT FULLY SUBSIDE UNTIL 4-18-06. HE HAD HX OF SEVERE DIPHTHERIA CONTRACTED AT AGE 5 YRS OLD.
Patient stated she had an asthma attack after she got home from her vaccination. She used a rescue inhaler and the symptoms subsided. Her doctor advised for her to receive the second dose.
Subject suffered a massive heart attack while mowing the law .      May be attributable to the Covid vaccine as the subject had been to the cardiologist prior to both vaccine and EKG and Stress test were perfectly normal
Initial information received on 16-Nov-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves a 10 years old male patient who experienced tingling and numbness from his elbow down to fingers, the 5th, 4th and 3rd fingers were particularly affected and pain, redness and swelling at the injection site, while he received vaccines FLUZONE QUADRIVALENT and ADACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were not reported. On 15-Nov-2018, the patient received a 0.5 ml dose of suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine (lot C5519AA and expiration date 12-Sep-2020) via intramuscular route in unknown administration site. On the same day, the patient also received a 0.5 ml dose of suspect Influenza Quadrival A-B Vaccine (lot number not reported) via intramuscular route in unknown administration site. On 15-Nov-2018, the patient developed a non-serious tingling (paraesthesia) and numbness from his elbow down to fingers, the 5th, 4th and 3rd fingers were particularly affected (hypoaesthesia) within 20 minutes following the administration of Diphtheria-2/Tetanus/5 AC Pertussis Vaccine and Influenza Quadrival A-B Vaccine. Till 16-Nov-2018, the symptoms continued and he was evaluated by the physician. Physician reported that his strength was good and was able to squeeze hands equally. ROM fair. On an unknown date, the patient developed a non-serious pain, redness and swelling at the injection site (vaccination site inflammation) following the administration of Diphtheria-2/Tetanus/5 AC Pertussis Vaccine and following the administration of Influenza Quadrival A-B Vaccine. (Other relevant tests included No lab data.) Final diagnosis was pain, redness and swelling at the injection site, numbness from his elbow down to fingers, the 5th, 4th and 3rd fingers were particularly affected and tingling. It was not reported if the patient received a corrective treatment. Physician recommended ibuprofen and cool compress. The patient outcome is reported as Unknown for tingling, numbness from his elbow down to fingers, the 5th, 4th and 3rd fingers were particularly affected and pain, redness and swelling at the injection site. List of documents held by sender: none.
sent from rehab for covid+ test, requiring 2L nasal cannula, started on remdesivir
pt recvd vax 18NOV94 & w/in 1/2 an hr pt started to feel weak & tired; pt went home early & slept whole weekend; returned to work 20NOV; 1DEC noted numbness & coolness of both feet; 5DEC fell at work & was taken to hosp; dx GBS;
redness; swelling; It was less severe; rash from shoulder to elbow; 101F temperature on the same right arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), SWELLING (swelling), FEELING ABNORMAL (It was less severe), RASH (rash from shoulder to elbow) and PYREXIA (101F temperature on the same right arm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, OMEPRAZOLE, ESTRADIOL, CHORIONIC GONADOTROPHIN (PROVIGIL [CHORIONIC GONADOTROPHIN]), ATORVASTATIN, VITAMINS NOS, CALCIUM (CALCIUM Vitamin D3 magnesium), LORATADINE and LIPOIC ACID (alpha LIPOIC ACID) for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced ERYTHEMA (redness), SWELLING (swelling), FEELING ABNORMAL (It was less severe), RASH (rash from shoulder to elbow) and PYREXIA (101F temperature on the same right arm). At the time of the report, ERYTHEMA (redness), SWELLING (swelling), FEELING ABNORMAL (It was less severe), RASH (rash from shoulder to elbow) and PYREXIA (101F temperature on the same right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information were not provided.   This case was linked to MOD-2021-089452 (Patient Link).
Pt seen in office 6/02/17 for checkup. Rec'd (11-12yr) vaccines. Reports (LT) arm with mild redness and edema next day. (+) warmth noted. (+) pain on 6/4/17. Less at time of 6/5/17. F.U. OV. (3x3cm pink, SL. Raised/warm area (LT) arm. Tx with TYLENOL or Ibuprofen.
COVID Vaccine Breakthrough Case  Moderna Dose 1 3/10/21 (040A21A) Moderna Dose 2 4/7/21 (006B21A) COVID Positive 11/2/21  11/2/21: Patient is an 82 male with pmhx of diabetes and hyperlipidemia coming in for shortness of breath of a few weeks duration. patient says he has been feeling short of breath especially with ambualtion for the past few weeks. he accompanied his wife to her clinic appointment, and supposedly was advised by the doctor there to go to the er as he was not looking too good. patient says he doesnt have any fevers, but has minimal coughing, nonbloody. he denies any chest pains. no nausea or vomiting. no diarrhea. he has been vaccinated against covid x2. he has known lung mass that is being followed by his pcp, with low suspicion for cancer.  11/12/21: Patient is an 82 male with pmhx of diabetes and hyperlipidemia coming in for shortness of breath of a few weeks duration. patient says he has been feeling short of breath especially with ambualtion for the past few weeks. he accompanied his wife to her clinic appointment, and supposedly was advised by the doctor there to go to the er as he was not looking too good. patient says he doesnt have any fevers, but has minimal coughing, nonbloody. he denies any chest pains. no nausea or vomiting. no diarrhea. he has been vaccinated against covid x2. he has known lung mass that is being followed by his pcp, with low suspicion for cancer.  Patient was admitted to icu for increasing oxygen requirements. pulmonary was consulted, and pateitn started on remdesivir and dexamethasone as well as antibiotics. he continued to desaturate, until he eventually required intubation 11/06/2021. he developed worsening renal function, with nephrology recommending possible dialysis for his anuria. eventually family elected to make patient comfort care. patient expired 11/12/2021.
HYPERSENSITIVITY REACTION {HYPERSENSITIVITY NOS} {URTICARIA NOS} {MUSCLE SPASMS} {CHOKING SENSATION} An approximately 48 year old female patient experienced a hypersensitivity reaction while receiving RabAvert. The patient received injections of RabAvert on 09/13/2004 and 09/16/2004. Past medical history was an allergy to egg white with a reaction of cramps, nausea, and backache. Concomitant medications were not known. On 09/13/2004, the patient experienced a bite on the foot by a fox with a rabid appearance, that bit through her shoe but did not puncture the flesh. However, she then touched the saliva on her sock. Post exposure prophylaxis was initiated with human rabies immune globulin(HRIG), Tetanus toxoid and the first RabAvert dose. The patient complained of hives afterwards, assessed by the health care provider as nervousness. On 0916/2004 she was pre-medicated with 25mg oral Benadryl and received the second RabAvert injection. Two hours later while having lunch, the patient felt a choking sensation, had neck and throat spasms and spit out her sandwich. There were no other symptoms such as hives, erythema. swelling, or itching at that time. The patient was pre- medicated with 50 mg of Benadryl for the third RabAvert injection but the injection was held as the health department had no emergency resuscitative equipment on hand, and was not comfortable with administering the vaccine. The treatment plan was to finish the vaccine series with three doses of Imovax. The hives and laryngospasm resolved.
Left arm redness and swelling which occurred less than 24 hrs after injection of PNEUMOVAX.
extreme, crushing fatigue, brain fog, screaming tinnitus 24/7 right ear. extreme insomnia, burning mouth syndrome, burning, tingling in hand, feet . difficulty concentrating, joint pain, irregular heartbeat extremely dry eyes. GI issues, never had them.
local reaction, swelling and redness of left thigh, cellulitis- treated with Keflex for 7 days
Approximately a day and a half after the first dose I started to experience severe swelling in my neck and chest on the left side of my body (vaccine site side). The swelling reduced a little 3 days later and then returned on day 5 after the vaccine.  The swelling in my neck and chest have extended to my left armpit/breast. It is sore to touch.
Developed raised area L upper lip, panick attack.  Felt like throat closure.   Sent to ED
5:28pm received 1st Covid-19 vaccine. At 5:40 c/o slight throat tightness. O2 sat 99, Pulse 100, B/P 128/80. At 5:45pm c/o tongue tingling. 5:49pm hives on chest and c/o chest tightness. Denies SOB. O2 sat 99, pulse 130, B/P 124/72. 5:50pm 0.5 mg Epi administered IM left thigh and EMS activated. 5:50pm pulse 110, B/P 130/82, O2 sat 98%. Transported to hospital at 6:02pm per ambulance.
A non-serious spontaneous report of inadvertent eye administration of H1N1 was received from medical assistant/non-health professional concerning a 30-year-old male. The patient's medical history was not reported. On 05-Jan-2010, a portion of H1N1, Intranasal was inadvertently administered to the patient's eye. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable and the event was considered resolved.
SIRVA for 2 weeks followed by progressive chronic polyneuropathy for the last 2 years
Rash around the area of injection - approx. 4 inch in diameter; Itchiness; This is a spontaneous report from a contactable consumer. A 75-years-old non-pregnant female patient received BNT162B2(Solution for injection, Lot Number: EN6205), dose 2 via an unspecified route of administration, administered in Arm Left on 03Mar2021 18:00 as 2nd dose, single dose for COVID-19 immunization. No other vaccine administered in four weeks. Patient did not have covid prior vaccination. Medical history included known allergies to Sulfa drugs, penicillin. Concomitant medications included in two weeks included ascorbic acid, betacarotene, biotin, calcium, chromium, colecalciferol, copper, folic acid, iodine, iron, lycopene, magnesium, manganese, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, xantofyl, zinc (CENTRUM SILVER), PREVALENT, calcium citrate (CITRACAL), and estradiol. The patient previously took BNT162B2(Lot Number: EL9264), dose 1 via an unspecified route of administration, administered in Arm Left on 10Feb2021 17:15 as 1st dose, single dose for COVID-19 immunization.  On 05Mar2021, the patient experienced rash around the area of injection - approx. 4 inch in diameter and itchiness. Patient did not have covid tested post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
temperature of 102 (2nd dose); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature of 102 (2nd dose)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (temperature of 102 (2nd dose)). At the time of the report, PYREXIA (temperature of 102 (2nd dose)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102.         On 02-Nov-2021, the patient received her booster dose of the Moderna COVID-19 vaccine.  No concomitant medications reported by reporter No treatment medications provided by the reporter.     This case was linked to MOD-2021-392266 (Patient Link).
C/O severe pain in left shoulder and arm since receiving flu shot on 10/17/09.
the tips of my fingers Hurt and feel hot and cold. I can't  pick up things with both  hands as my fingers are like frozen.
Slight fatigue in the afternoon.  Was a little chilled at 10PM. At midnight, I had severe chills and could not get warm. Around 1:00 AM, I had fever followed by sweats. Then more chills and fever and sweats. Then more chills and fever and sweats. Symptoms were gone by morning except for fatigue that could have been from lack of sleep. Was tired most of that day (day after shot). Had slight chills and sweats the next night. By morning two (3/27. shot was received on 3/25) symptoms were gone.
rash on arms, legs, and body (not hives, doesn't itch)--red splotchy spots, clearing up now on 6/2/22
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. The nurse reported that on 29-JUL-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # K009953, expiry date 03-APR-2016 (dose and route of administration unspecified). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested
Patient given Moderna vaccine at off-site clinic and was not eligible due to age restriction of 18 years old